Literature DB >> 18619509

Application of quantitative gene expression analysis for pertussis vaccine safety control.

Isao Hamaguchi1, Jun-ichi Imai, Haruka Momose, Mika Kawamura, Takuo Mizukami, Seishiro Naito, Jun-ichi Maeyama, Atsuko Masumi, Madoka Kuramitsu, Kazuya Takizawa, Hiroshi Kato, Tetsuya Mizutani, Yoshinobu Horiuchi, Nobuo Nomura, Shinya Watanabe, Kazunari Yamaguchi.   

Abstract

Although vaccines are routinely used to prevent infectious diseases, little is known about the comprehensive influences caused by vaccines. In this study, we showed, using comprehensive gene expression analysis, that pertussis vaccine affected many genes in multiple organs of vaccine-treated animals. In particular, lung was revealed to be the most suitable target to evaluate pertussis vaccine toxicity. The 13 genes identified from the analysis of vaccine-treated lung at day 1 showed a clear dendrogram corresponding to pertussis vaccine toxicity. Furthermore, quantitative analysis of these genes revealed a positive correlation between their respective expression levels and the degree of toxic effects observed in samples that had been treated with various doses of reference pertussis vaccines. The quantification of this 13 gene-set is an indicator of the vaccine toxicity-related reaction.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18619509     DOI: 10.1016/j.vaccine.2008.06.086

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  10 in total

1.  In vivo study of hepatitis B vaccine effects on inflammation and metabolism gene expression.

Authors:  Heyam Hamza; Jianhua Cao; Xinyun Li; Shuhong Zhao
Journal:  Mol Biol Rep       Date:  2011-06-21       Impact factor: 2.316

Review 2.  A new method for the evaluation of vaccine safety based on comprehensive gene expression analysis.

Authors:  Haruka Momose; Takuo Mizukami; Masaki Ochiai; Isao Hamaguchi; Kazunari Yamaguchi
Journal:  J Biomed Biotechnol       Date:  2010-06-13

Review 3.  Strategic applications of gene expression: from drug discovery/development to bedside.

Authors:  Jane P F Bai; Alexander V Alekseyenko; Alexander Statnikov; I-Ming Wang; Peggy H Wong
Journal:  AAPS J       Date:  2013-01-15       Impact factor: 3.603

4.  Establishment of a new quality control and vaccine safety test for influenza vaccines and adjuvants using gene expression profiling.

Authors:  Haruka Momose; Takuo Mizukami; Madoka Kuramitsu; Kazuya Takizawa; Atsuko Masumi; Kumiko Araki; Keiko Furuhata; Kazunari Yamaguchi; Isao Hamaguchi
Journal:  PLoS One       Date:  2015-04-24       Impact factor: 3.240

5.  Modeling for influenza vaccines and adjuvants profile for safety prediction system using gene expression profiling and statistical tools.

Authors:  Eita Sasaki; Haruka Momose; Yuki Hiradate; Keiko Furuhata; Mamiko Takai; Hideki Asanuma; Ken J Ishii; Takuo Mizukami; Isao Hamaguchi
Journal:  PLoS One       Date:  2018-02-06       Impact factor: 3.240

Review 6.  Assays for Determining Pertussis Toxin Activity in Acellular Pertussis Vaccines.

Authors:  Kevin Markey; Catpagavalli Asokanathan; Ian Feavers
Journal:  Toxins (Basel)       Date:  2019-07-17       Impact factor: 4.546

7.  Changes of urine metabolite profiles are induced by inactivated influenza vaccine inoculations in mice.

Authors:  Eita Sasaki; Hideki Kusunoki; Haruka Momose; Keiko Furuhata; Kazuo Hosoda; Kaori Wakamatsu; Takuo Mizukami; Isao Hamaguchi
Journal:  Sci Rep       Date:  2019-11-07       Impact factor: 4.379

Review 8.  In Vivo Models and In Vitro Assays for the Assessment of Pertussis Toxin Activity.

Authors:  Marieke Esther Hoonakker
Journal:  Toxins (Basel)       Date:  2021-08-12       Impact factor: 4.546

9.  System vaccinology for the evaluation of influenza vaccine safety by multiplex gene detection of novel biomarkers in a preclinical study and batch release test.

Authors:  Takuo Mizukami; Haruka Momose; Madoka Kuramitsu; Kazuya Takizawa; Kumiko Araki; Keiko Furuhata; Ken J Ishii; Isao Hamaguchi; Kazunari Yamaguchi
Journal:  PLoS One       Date:  2014-07-10       Impact factor: 3.240

10.  iGIST-A Kinetic Bioassay for Pertussis Toxin Based on Its Effect on Inhibitory GPCR Signaling.

Authors:  Valeriy M Paramonov; Cecilia Sahlgren; Adolfo Rivero-Müller; Arto T Pulliainen
Journal:  ACS Sens       Date:  2020-11-04       Impact factor: 7.711

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.